Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical organizations, like the makers of Xarelto, possess a duty to ensure that their drugs are reasonably protected for use – and failure to do so could be grounds for compensation. Our lawyers are functioning difficult to have these hurt by the drug the compensation they are entitled to.
Although bleeding is a common complication associated with anticoagulants, it has been alleged that xarelto how long to stop before surgery is more harmful than conventional blood thinners since no antidote exists to reverse its blood-thinning effects. This implies that, in the occasion of an emergency, individuals might be at risk for irreversible bleeding troubles, such as life-threatening internal and gastrointestinal hemorrhaging.
Should you or possibly a loved 1 suffered a significant bleeding occasion following taking Xarelto, you may have legal recourse. For much more details, make contact with us right now to possess your case reviewed, free of charge.
xarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for past and future medical bills, lost wages, pain and suffering and, in circumstances of death, funeral expenses. Moreover, they are looking for punitive damages, which are generally awarded to punish the defendant and deter other companies from acting similarly.
Why Are Lawsuits Being Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Due to the fact of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding within the occasion of an emergency. Plaintiffs inside the lawsuits allege serious and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a protected anticoagulant option.
Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto is linked to significant bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing unsafe clotting.
Visit this page for a lot more information on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.